Emerson sees FY13 EPS $3.53-$3.63, consensus $3.59 The company says business investment remains slow and cautious globally, especially in Europe. Visibility remains challenging, but reported and underlying sales in 2013 are expected to grow 2%-5%.
Emerson downgraded at BofA/Merrill As previously reported, BofA/Merrill downgraded Emerson to Underperform from Neutral. The firm reduced forecasts below consensus based on expectations Process organic growth will decline in 2016 and 2017 and pressure the stock multiple. Price target lowered to $62 from $66.